Mayer B. Davidson - Publications, H-index & Citations

Mayer B. Davidson

charles r. drew university of medicine & science

50H指数

397论文数

1.7W被引数

收录论文 134

发表时间

The Effective Use by Primary Care Clinicians of a Comprehensive Computerized Insulin Dose Adjustment Algorithm

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2024-12-23

PREAI

Davidson, Mayer B.

Comment on Mittendorfer et al. Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia

DIABETES

IF7.5

2024-10-21

PREAI

Davidson, Mayer B.

In adults with hypertension and high CV risk, intensive vs. standard BP-lowering therapy reduced major vascular events

ANNALS OF INTERNAL MEDICINE

IF15.2

2024-10-01

PREAI

Davidson, Mayer B.

Glycaemic treatment of newly diagnosed type 2 diabetes

DIABETES OBESITY & METABOLISM

IF5.7

2024-08-29

PREAI

Davidson, Mayer B.

Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians

DIABETES OBESITY & METABOLISM

IF5.7

2024-06-11

PREAI

Davidson, Mayer B.; Davidson, S. Joshua

In adults with BMI ≥27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk

ANNALS OF INTERNAL MEDICINE

IF15.2

2023-11-01

PREAI

Davidson, Mayer B.

Review of Prediabetes

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2023-08-08

PREAI

Davidson, Mayer B.

A simplified straightforward protocol for the use of U-500 regular insulin

DIABETES OBESITY & METABOLISM

IF5.7

2022-11-08

PREAI

Davidson, Mayer B.

In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk

ANNALS OF INTERNAL MEDICINE

IF15.2

2022-10-01

PREAI

Davidson, Mayer B.

The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737

DIABETES CARE

IF16.6

2022-03-29

OAAI

Davidson, Mayer B.

Historical review of the diagnosis of prediabetes/intermediate hyperglycemia: Case for the international criteria

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2022-03-01

PREAI

Davidson, Mayer B.

Correction to the Bergman review

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2021-10-01

PREAI

Davidson, Mayer B.

Effective use of computerized insulin dose adjustment algorithms on continuous glucose monitoring results by a clinical pharmacist - Proof-of-concept 临床药剂师概念验证在连续血糖监测结果中有效使用计算机化胰岛素剂量调整算法

JOURNAL OF DIABETES

IF3.7

2021-01-19

PREAI

Davidson, Mayer B.; Davidson, Seth Joshua

Metformin Should Not Be Used to Treat Prediabetes

DIABETES CARE

IF16.6

2020-08-11

OAAI

Davidson, Mayer B.

The Cost-Effective beneficial effect of pioglitazone on cardiovascular disease

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2020-07-01

PREAI

Davidson, Mayer B.

Effective Use of Computerized Insulin Dose Adjustment Algorithms (CIDAA) on Continuous Glucose Monitoring (CGM) Results in Poorly Controlled Patients by a Clinical Pharmacist: A Proof-of-Concept Project

DIABETES

IF7.5

2020-06-01

PREAI

Davidson, Mayer B.; Davidson, Josh

YCOMMENT ON DAWSON-HUGHES ET AL. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922

DIABETES CARE

IF16.6

2020-05-10

OAAI

Davidson, Mayer B.

Diabetes, Obesity and Metabolism

DIABETES OBESITY & METABOLISM

IF5.7

2020-03-13

PREAI

Davidson, Mayer B.

SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists

ANNALS OF INTERNAL MEDICINE

IF15.2

2019-12-01

PREAI

Davidson, Mayer B.

Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study

JOURNAL OF DIABETES

IF3.7

2019-10-23

PREAI

Hsia, Stanley H.; Duran, Petra; Lee, Martin L.; Davidson, Mayer B.

研究方向